You Can Help Save Lives
We'll Help You Find Live Stem Cells

Discover the AQUIOS STEM System - An evolution of the gold standard

El nuevo rotor J-Lite JLA-12.500 para la serie Avanti JXN

Más información sobre el nuevo rotor

Sistema ClearLLab 10C:
Una potente solución para optimizar el flujo de trabajo de su laboratorio de L&L

ClearLLab 10C

Ahora tiene la capacidad de explorar partículas pequeñas.

Recursos de partículas pequeñas

Faster Viability Analysis and Processing Time

Discover What the Vi-CELL BLU Can Do For You

La Diferencia de Beckman Coulter Life Sciences

El compromiso de Beckman Coulter con su investigación se remonta a nuestro origen en 1935. Durante más de 80 años hemos sido un socio de confianza para los profesionales de laboratorio, ayudando a avanzar en la investigación científica y la atención al paciente. Beckman Coulter Life Sciences y Beckman.com es un recurso global en el que confían millones de investigadores de ciencias de la vida, técnicos industriales y medioambientales, y científicos farmacéuticos y biomédicos.

Obtener más información

Últimas noticias y actualizaciones

Press Release

Beckman Coulter Life Sciences Achieves Industry-First Reagent Certification to Help Prepare Labs for IVDR and to Clear Confusion

INDIANAPOLIS – (April 17, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

Más información
Press Release

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Más información
Press Release

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Más información